Company Filing History:
Years Active: 2014
Title: Frank Morich: Innovator in Hepcidin Binding Nucleic Acids
Introduction
Frank Morich is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of nucleic acids that interact with hepcidin. His work is crucial for advancing medical research and therapeutic applications.
Latest Patents
Frank Morich holds a patent for "Hepcidin binding nucleic acids." This invention relates to a nucleic acid capable of binding to hepcidin, which is a key regulator of iron metabolism in the body. The patent showcases his innovative approach to addressing health issues related to iron regulation.
Career Highlights
Frank Morich is associated with Noxxon Pharma AG, a company focused on developing innovative therapies. His role at Noxxon Pharma AG allows him to contribute to cutting-edge research and development in the pharmaceutical industry. His expertise in nucleic acids positions him as a valuable asset in the field.
Collaborations
Frank collaborates with talented professionals such as Simone Sell and Christian Maasch. These partnerships enhance the research and development efforts at Noxxon Pharma AG, fostering an environment of innovation and creativity.
Conclusion
Frank Morich is a distinguished inventor whose work on hepcidin binding nucleic acids has the potential to impact medical science significantly. His contributions, along with his collaborations, highlight the importance of innovation in addressing complex health challenges.